JPH115729A - Cosmetic having photocatalytic function - Google Patents
Cosmetic having photocatalytic functionInfo
- Publication number
- JPH115729A JPH115729A JP19632097A JP19632097A JPH115729A JP H115729 A JPH115729 A JP H115729A JP 19632097 A JP19632097 A JP 19632097A JP 19632097 A JP19632097 A JP 19632097A JP H115729 A JPH115729 A JP H115729A
- Authority
- JP
- Japan
- Prior art keywords
- titanium oxide
- powder
- skin
- base
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 16
- 230000001699 photocatalysis Effects 0.000 title claims abstract description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 32
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000010419 fine particle Substances 0.000 claims abstract description 12
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 239000002245 particle Substances 0.000 claims abstract description 6
- 244000005700 microbiome Species 0.000 abstract description 9
- 239000000843 powder Substances 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 239000013078 crystal Substances 0.000 abstract description 3
- 239000007787 solid Substances 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 239000011164 primary particle Substances 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004381 surface treatment Methods 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 21
- 238000009472 formulation Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000013032 photocatalytic reaction Methods 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000014692 zinc oxide Nutrition 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- -1 Sulfo-Zinc Phosphate Chemical compound 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229940105125 zinc myristate Drugs 0.000 description 1
- GBFLQPIIIRJQLU-UHFFFAOYSA-L zinc;tetradecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O GBFLQPIIIRJQLU-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【０００１】〔発明の属する技術分野〕本発明は皮膚表
面に光触媒性を持つ微粒子酸化チタンを塗布することに
より、光との反応で肌上の微生物を積極的に殺菌・分解
して、微生物由来の皮膚トラブルを避け、肌を清潔に保
つ化粧料に関するものである。[0001] The present invention relates to a method for applying microparticles of titanium oxide having photocatalytic properties to the surface of a skin to actively sterilize and decompose microorganisms on the skin by reaction with light, and The present invention relates to cosmetics that avoid skin problems and keep skin clean.
【０００２】〔従来の技術〕従来の化粧料は、微生物対
策として製剤中に防腐剤や殺菌剤を添加していたが、こ
れは微生物の増殖を抑えたり、殺菌したりするには充分
であるとはいえないレベルであつた。というのは、化粧
料を塗布した皮膚の表面は、ミクロに見ると微生物的に
は決してクリーンな状態とはいえず、製剤中の有機成
分、表皮の脂腺からの脂肪質や汗腺からの汗などの栄養
源と水分、それに温度まで、微生物の繁殖にとつて最適
な環境であり、無数の常在菌に更に手指や化粧用具から
の微生物まで加わつて、経時によつて繁殖しかねないも
のであつたが、今日まで、このような事に関しては殆ど
対策が打たれていなかつたのである。2. Description of the Related Art In conventional cosmetics, preservatives and bactericides have been added to pharmaceutical preparations as a countermeasure against microorganisms, but this is sufficient to suppress the growth of microorganisms and sterilize them. It was a level that could not be said. This is because the surface of the skin to which the cosmetic is applied is not microscopically clean when viewed microscopically, and the organic components in the preparation, fat from the sebaceous glands of the epidermis, and sweat from the sweat glands Nutrient sources such as nutrients, water, and temperature are the most suitable environment for the propagation of microorganisms. However, to date, little has been done about such things.
【０００３】〔発明が解決しようとする課題〕元々、化
粧料の使用目的は、肌を健やかに保ち美しく粧うことで
ある。そのためには、肌に適切な水分や油分や有効成分
などを補充したり、老化を促進する紫外線から守ること
などが最優先であるが、塗布している最中での化粧料の
微生物汚染による肌への悪影響を無視することはできな
い。特に、肌が過敏であつたりかぶれたりしてる時は重
大である。通常、微生物汚染による被害を防止するた
め、国毎に製剤レベルで、微生物の一般生菌数・一般真
菌数の規制や、大腸菌、黄色ブドウ球菌や緑膿菌の特定
菌の存在を認めない、などの品質基準値を設けてはいる
が、現実問題としては、製剤はクリーンであつても肌に
塗布する際の汚れた手指や用具によつて持ち込まれた多
くの雑菌や有害な特定菌の弊害については、まつたく無
防備であつた。本発明は、化粧料が塗布された後から除
去されるまでの皮膚安全性を更に強化する化粧料の開発
を課題とした。[Problems to be Solved by the Invention] Originally, the purpose of using cosmetics is to keep the skin healthy and make it beautiful. For that purpose, the top priority is to replenish the skin with appropriate moisture, oil and active ingredients, and to protect it from ultraviolet rays that promote aging.However, due to microbial contamination of cosmetics during application, The negative effects on the skin cannot be ignored. This is especially true when your skin is too sensitive or rashy. Usually, in order to prevent damage caused by microbial contamination, at the formulation level in each country, regulation of the number of general viable bacteria and general fungi and the presence of specific bacteria such as Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa are not recognized. Despite the fact that the product is clean, even though the product is clean, there are many bacteria and harmful specific bacteria introduced by dirty fingers and tools when applying it to the skin. As for the evil, he was vulnerable. An object of the present invention is to develop a cosmetic that further enhances skin safety after the cosmetic is applied until it is removed.
【０００４】〔課題を解決するための手段〕本発明は、
皮膚に対する化粧料の安全性をまつたく損なうことな
く、塗布した製剤中の微生物を消滅させるために、製剤
中に皮膚に悪影響を及ぼさない、光触媒機能を有する微
粒子酸化チタンを配合することによつて、微生物類を肌
の表面で一気に殺菌・分解させることを狙つたものであ
る。一般の防腐剤や殺菌剤、銀や銅イオンによる抗菌作
用では、殺菌はできても死骸が残つてしまうが、酸化チ
タンの光触媒反応ではこの死骸までも分解することがで
きる。[Means for Solving the Problems]
In order to eliminate microorganisms in the applied preparation without impairing the safety of the cosmetic on the skin, by incorporating fine particulate titanium oxide having a photocatalytic function, which does not adversely affect the skin, in the preparation. It is intended to disinfect and decompose microorganisms at once on the surface of the skin. With the antibacterial action of general preservatives, bactericides, and silver and copper ions, the carcass remains even if sterilization is possible, but even the carcass can be decomposed by the photocatalytic reaction of titanium oxide.
【０００５】〔発明の実施の形態〕微粒子酸化チタンを
配合する化粧料を、製剤処方系で分類すると、粉末系、
粉末固型系、粉末−水系、粉末−油系、粉末−乳化系な
どになるが、いずれの系に於いても、微粒子酸化チタン
を製剤中に、均一に混合分散して一次粒子化すること
が、効果を最大限発揮させるための必要条件となるた
め、製造プロセス面での高度な技術力が不可欠である。[Embodiment of the Invention] Cosmetics containing fine particulate titanium oxide are classified according to the formulation and formulation system.
Powdered solid system, powder-water system, powder-oil system, powder-emulsification system, etc.In any system, fine particles of titanium oxide must be uniformly mixed and dispersed in the formulation to form primary particles. However, this is a necessary condition for maximizing the effect, so that a high level of technical skills in the manufacturing process is indispensable.
【０００６】微粒子酸化チタンの光触媒作用は、光が当
たるとそれ自体は変わらずに、酸化チタンの表面に接触
している有機物を強力に酸化分解するが、光の直接照射
されない皮膚表面ではまつたく不活性である。したがつ
て、この作用は肌に塗布された製剤の外面に存在してい
る粒子結晶によつてのみ促進される。[0006] The photocatalytic action of the fine particle titanium oxide does not change itself when exposed to light, but strongly oxidizes and decomposes organic substances in contact with the surface of the titanium oxide. Inactive. Thus, this effect is only enhanced by the particle crystals present on the outer surface of the formulation applied to the skin.
【０００７】〔実施例〕 （粉白粉） 原料名 配合量（％） タルク ４５．５ マイカ ２０．０ 酸化チタン（アナターゼ） ３．０ 亜鉛華 ５・０ ＊微粒子酸化チタン（アナターゼ）１０．０ ジンクミリステート ９．５ ベンガラ ０．９ 黄酸化鉄 ２．１ スクワラン ３．０ ニツコールＳＯ−１０ ０．７ 香料 ０．３ 合計 １００．０％ ＊ 化粧用具のパフを使つて顔全体を化粧する。[Example] (Powder powder) Raw material name Content (%) Talc 45.5 Mica 20.0 Titanium oxide (anatase) 3.0 Zinc white 5.0 * Fine particle titanium oxide (anatase) 10.0 Zinc Myristate 9.5 Bengala 0.9 Yellow iron oxide 2.1 Squalane 3.0 Nitsukol SO-10 0.7 Fragrance 0.3 Total 100.0% * Make up the entire face using the puff of cosmetic tools.
【０００８】 （ルース・パウダー）原料名 配合量（％） タルク ２３．９ セリサイト ２５．０ ＊微粒子酸化チタン（アナターゼ）４０．０ マグネシユウム・ミリステート １０．０ ベンガラ ０．３ 黄酸化鉄 ０．７ 香料 ０．１ 合計 １００．０％ ＊ 化粧用具の、毛足が長くて肌にソフトなムウトン・パフなどを用いて 顔の化粧の最終仕上げを行い、肌を薄い粉末膜で覆う。(Loose powder) Raw material name Content (%) Talc 23.9 Sericite 25.0 * Fine particle titanium oxide (anatase) 40.0 Magnesium myristate 10.0 Bengala 0.3 Yellow iron oxide 0. 7 Perfume 0.1 Total 100.0% * Make a final finish of face makeup using long-haired and soft skin mutton puff, etc. of cosmetic tools, and cover the skin with a thin powder film.
【０００９】 （粉末化粧水） 原料名 配合量（％） 亜鉛華 １．０ カオリン ０．３ セリサイト ０．７ ＊微粒子酸化チタン（アナターゼ） １．０ ベンガラ ０．１ １，３−ブチレングリコール ２．０ カンフアー ０．１ フエノール ０．０５ エタノール ３．０ スルホ−石炭酸亜鉛 ０．０３ 香料 ０．０２ イオン交換水 ９１．７ 合計 １００．００％ ＊ 日焼けした顔、首、手足を対象にして肌の炎症やホテリを抑えるため カツト綿などに含ませて肌をパツテイングする。(Powder lotion) Raw material name Content (%) Zinc white 1.0 Kaolin 0.3 Sericite 0.7 * Fine particle titanium oxide (anatase) 1.0 Bengala 0.1 1,3-butylene glycol 2 0.0 Camphor 0.1 Phenol 0.05 Ethanol 3.0 Sulfo-Zinc Phosphate 0.03 Fragrance 0.02 Ion-exchanged Water 91.7 Total 100.00% * Skin for tanned face, neck and limbs To reduce inflammation and hotness, cut the skin by putting it in a cotton cloth.
【００１０】 （粉末固形白粉） 原料名 配合量（％） タルク ３０．９９ セリサイト ２５．０ マイカ １７．５ 酸化チタン（ルチル） ３．０ 亜鉛華 ２．０ ＊微粒子酸化チタン（ルチル） ７．０ べんがら ０．７ 黄酸化鉄 １．９ エチルパラベン ０．３ スクワラン ３．５ 水添ラノリン ５．５ シリコンオイル ２・０ ニツコールＳＩ−１０ ０．２ ビタミンＥ−アセテート ０．０１ 香料 ０．４ 合計 １００．００％ ＊ 携帯用のメイクアツプ化粧品として、パフやスポンジを用いて顔に化 粧を施し、化粧直しなどにも便利に使われる。(Powder solid white powder) Material name Compounding amount (%) Talc 30.99 sericite 25.0 Mica 17.5 Titanium oxide (rutile) 3.0 Zinc white 2.0 * Fine particle titanium oxide (rutile) 7. 0 Bengal 0.7 Iron yellow oxide 1.9 Ethyl paraben 0.3 Squalane 3.5 Hydrogenated lanolin 5.5 Silicon oil 2.0 Nitsukol SI-10 0.2 Vitamin E-acetate 0.01 Perfume 0.4 Total 100.00% * As a make-up cosmetic for portable use, it is used to apply makeup to the face using puffs and sponges, and is also useful for makeup repair.
【００１１】〔発明の効果〕皮膚と製剤との接触面で
は、光が遮蔽されているため光触媒反応はまつたく起こ
らず、皮膚への悪影響はない。[Effect of the Invention] At the contact surface between the skin and the preparation, since the light is shielded, the photocatalytic reaction does not occur quickly, and there is no adverse effect on the skin.
【００１２】微粒子酸化チタンによる光触媒反応は、僅
か１マイクロメートル以下の厚さに塗布した薄膜でも、
蛍光燈程度の光を照射するだけでも、促進される。The photocatalytic reaction by the fine particle titanium oxide can be performed on a thin film applied to a thickness of only 1 micrometer or less.
Irradiation with light such as a fluorescent lamp is also promoted.
【００１３】微粒子チタンの結晶表面は、非常に光活性
なためやたらに表面処理を施して機能低下させない工夫
が必要である。又、ルチル型に比べてアナターゼ型は、
より光活性が強く透明性が高いので、製剤特性に応じて
選択して使い分ける。Since the crystal surface of the fine titanium particles is very photoactive, it is necessary to devise a surface treatment so as not to deteriorate the function. In addition, compared to the rutile type, the anatase type
Since they have higher photoactivity and higher transparency, they are selected and used depending on the formulation characteristics.
【００１４】微粒子酸化チタンを製剤に配合することに
よつて、光を受けている間は塗布表面で常に光触媒反応
が進行し、肌上の微生物はしだいに減少してしまうので
微生物汚染による皮膚トラブルは解消される。[0014] By incorporating the fine particle titanium oxide into the preparation, the photocatalytic reaction always proceeds on the coated surface while receiving the light, and the microorganisms on the skin are gradually reduced. Is eliminated.
Claims (1)
ナノメートルの微粒子酸化チタンを、製剤中に１４０重
量％均一に配合することを特徴とした化粧料。1. A particle having a particle diameter of 10 to 50 having a photocatalytic function.
A cosmetic, characterized in that nanometer-sized fine particle titanium oxide is uniformly mixed at 140% by weight in a preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19632097A JPH115729A (en) | 1997-06-17 | 1997-06-17 | Cosmetic having photocatalytic function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19632097A JPH115729A (en) | 1997-06-17 | 1997-06-17 | Cosmetic having photocatalytic function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH115729A true JPH115729A (en) | 1999-01-12 |
Family
ID=16355865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19632097A Pending JPH115729A (en) | 1997-06-17 | 1997-06-17 | Cosmetic having photocatalytic function |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH115729A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2850270A1 (en) * | 2003-01-27 | 2004-07-30 | Oreal | USE OF A PHOTOCATALYST FOR THE TREATMENT OF FAT HAIR |
| JP2012193128A (en) * | 2011-03-15 | 2012-10-11 | Pola Chemical Industries Inc | Powdery cosmetics for reapplying makeup |
| WO2016111285A1 (en) * | 2015-01-06 | 2016-07-14 | 山田 修 | Medicinal composition, blood treatment device, cosmetic, food and drink using combustion synthesis material |
| KR20200111355A (en) * | 2019-03-19 | 2020-09-29 | 강창현 | Portable bacteria identification and removal apparatus |
-
1997
- 1997-06-17 JP JP19632097A patent/JPH115729A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2850270A1 (en) * | 2003-01-27 | 2004-07-30 | Oreal | USE OF A PHOTOCATALYST FOR THE TREATMENT OF FAT HAIR |
| WO2004075680A3 (en) * | 2003-01-27 | 2004-10-21 | Oreal | Use of a photocatalyst for the treatment of oily hair |
| JP2012193128A (en) * | 2011-03-15 | 2012-10-11 | Pola Chemical Industries Inc | Powdery cosmetics for reapplying makeup |
| WO2016111285A1 (en) * | 2015-01-06 | 2016-07-14 | 山田 修 | Medicinal composition, blood treatment device, cosmetic, food and drink using combustion synthesis material |
| CN107106600A (en) * | 2015-01-06 | 2017-08-29 | 山田修 | Pharmaceutical compositions, blood treatment devices, cosmetics, and food and beverages utilizing combustion synthetic materials |
| JPWO2016111285A1 (en) * | 2015-01-06 | 2017-10-12 | 山田 修 | Pharmaceutical composition, blood processing apparatus, cosmetics and food and drink using combustion synthetic material |
| US10471096B2 (en) | 2015-01-06 | 2019-11-12 | Osamu Yamada | Medicinal composition, blood treatment device, cosmetic, food and drink using combustion synthesis material |
| TWI713485B (en) * | 2015-01-06 | 2020-12-21 | 山田修 | Medical compositions, blood treatment devices, cosmetics and food and beverages using burning synthetic materials |
| KR20200111355A (en) * | 2019-03-19 | 2020-09-29 | 강창현 | Portable bacteria identification and removal apparatus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Allaker | The use of nanoparticles to control oral biofilm formation | |
| CN101588715B (en) | Material, item and products comprising a composition having anti-microbial properties | |
| CN1845716B (en) | Body care products containing porous silver particles | |
| US5767109A (en) | Complexing urushiols | |
| JP2009007266A (en) | Silver ion water for cosmetics and hypoallergenic cosmetics using the same | |
| DE60238187D1 (en) | SPICY COMPOSITION TO ENHANCEMENT | |
| JP2020111567A (en) | Nano-activator having high effects for improving stains, whitening, and moisturizing and method for preparing the same | |
| CN108904424A (en) | Lip care lipstick with maintenance effect | |
| EP2111846B1 (en) | Cosmetic preparation containing polyfunctional composite powder | |
| Al-Fadhily et al. | A novel coating of orthodontic archwires with chlorhexidine hexametaphosphate nanoparticles | |
| JPH115729A (en) | Cosmetic having photocatalytic function | |
| Eslami et al. | Biocompatibility of several colloidal solutions containing nanoparticles on human gingival fibroblasts | |
| EP2720755B1 (en) | Compositions for depositing agents using highly volatile silicone solvents | |
| JP2000159632A (en) | Skin antimicrobial composition | |
| US5453266A (en) | Powdered body deodorant composition | |
| JP5346533B2 (en) | Powdered solid antiperspirant deodorant | |
| Haneke | Onychocosmeceuticals | |
| Ibegbulam-Njoku et al. | Microbiological evaluation of cosmetics products sourced in Aba city, Nigeria | |
| EP3313415B1 (en) | Composition for the prevention of microbial growth | |
| CN120284753A (en) | A transparent sunscreen composition and its preparation method and application | |
| JPH10194953A (en) | Antibacterial cosmetic | |
| JP2012206991A (en) | Skin care preparation | |
| JPH10194929A (en) | Antimicrobial pigment for cosmetic, production of the pigment, and cosmetic composition containing the pigment | |
| Parinitha et al. | Comparison of the effect of propolis varnish and green tea varnish on treatment of dentinal hypersensitivity: An in vitro scanning electron microscope study | |
| Vanapatla et al. | Antibacterial efficacy of herbal solutions in disinfecting gutta percha cones against Enterococcus faecalis |